Literature DB >> 22245457

Insulin resistance in the nervous system.

Bhumsoo Kim1, Eva L Feldman.   

Abstract

Metabolic syndrome is a cluster of cardiovascular risk factors including obesity, diabetes and dyslipidemia. Insulin resistance (IR) is at the core of metabolic syndrome. In adipose tissue and muscle, IR results in decreased insulin signaling, primarily affecting downstream phosphatidylinositol 3-kinase (PI3K)/Akt signaling. It was recently proposed that neurons can develop hyperinsulinemia-induced IR, which in turn results in injury to the peripheral and central nervous systems and is probably pathogenic in common neurological disorders such as diabetic neuropathy and Alzheimer's disease (AD). This review presents evidence indicating that, similarly to insulin-dependent metabolically active tissues such as fat and muscle, neurons also develop IR and thus cannot respond to the neurotrophic properties of insulin, resulting in neuronal injury, subsequent dysfunction and disease states. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22245457      PMCID: PMC3392648          DOI: 10.1016/j.tem.2011.12.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  80 in total

1.  Role for neuronal insulin resistance in neurodegenerative diseases.

Authors:  Markus Schubert; Dinesh Gautam; David Surjo; Kojihiko Ueki; Stephanie Baudler; Dominic Schubert; Tatsuya Kondo; Jens Alber; Norbert Galldiks; Eckehardt Küstermann; Saskia Arndt; Andreas H Jacobs; Wilhelm Krone; C Ronald Kahn; Jens C Brüning
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

Review 2.  Diabetic neuropathies: a statement by the American Diabetes Association.

Authors:  Andrew J M Boulton; Arthur I Vinik; Joseph C Arezzo; Vera Bril; Eva L Feldman; Roy Freeman; Rayaz A Malik; Raelene E Maser; Jay M Sosenko; Dan Ziegler
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

Review 3.  The role of insulin receptor signaling in the brain.

Authors:  Leona Plum; Markus Schubert; Jens C Brüning
Journal:  Trends Endocrinol Metab       Date:  2005-03       Impact factor: 12.015

Review 4.  Tau phosphorylation in Alzheimer's disease: pathogen or protector?

Authors:  Hyoung-Gon Lee; George Perry; Paula I Moreira; Matthew R Garrett; Quan Liu; Xiongwei Zhu; Atsushi Takeda; Akihiko Nunomura; Mark A Smith
Journal:  Trends Mol Med       Date:  2005-04       Impact factor: 11.951

5.  The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses.

Authors:  M A Abbott; D G Wells; J R Fallon
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

6.  Insulin as an in vivo growth factor.

Authors:  Q-G Xu; X-Q Li; S A Kotecha; C Cheng; H S Sun; D W Zochodne
Journal:  Exp Neurol       Date:  2004-07       Impact factor: 5.330

7.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.

Authors:  M J Young; A J Boulton; A F MacLeod; D R Williams; P H Sonksen
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

8.  Direct insulin signaling of neurons reverses diabetic neuropathy.

Authors:  Valentine Brussee; F Alexander Cunningham; Douglas W Zochodne
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

9.  The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group.

Authors: 
Journal:  Ann Intern Med       Date:  1995-04-15       Impact factor: 25.391

Review 10.  Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications.

Authors:  J Zdychová; R Komers
Journal:  Physiol Res       Date:  2005       Impact factor: 1.881

View more
  99 in total

1.  Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function.

Authors:  Zoe Arvanitakis; Hoau-Yan Wang; Ana W Capuano; Amber Khan; Bouchra Taïb; Frederick Anokye-Danso; Julie A Schneider; David A Bennett; Rexford S Ahima; Steven E Arnold
Journal:  Ann Neurol       Date:  2020-07-27       Impact factor: 10.422

Review 2.  TRPCing around the hypothalamus.

Authors:  Martin J Kelly; Jian Qiu; Oline K Rønnekleiv
Journal:  Front Neuroendocrinol       Date:  2018-05-31       Impact factor: 8.606

Review 3.  New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.

Authors:  Kai Long Zhong; Fang Chen; Hao Hong; Xuan Ke; Yang Ge Lv; Su Su Tang; Yu Bing Zhu
Journal:  Metab Brain Dis       Date:  2018-04-06       Impact factor: 3.584

4.  MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.

Authors:  Woori Kim; Haneul Noh; Yenarae Lee; Jeha Jeon; Arthi Shanmugavadivu; Donna L McPhie; Kwang-Soo Kim; Bruce M Cohen; Hyemyung Seo; Kai C Sonntag
Journal:  Mol Neurobiol       Date:  2014-11-19       Impact factor: 5.590

Review 5.  The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease.

Authors:  Bhumsoo Kim; Sarah E Elzinga; Rosemary E Henn; Lisa M McGinley; Eva L Feldman
Journal:  Neurobiol Dis       Date:  2019-07-23       Impact factor: 5.996

6.  Brain insulin resistance and altered brain glucose are related to memory impairments in schizophrenia.

Authors:  S Andrea Wijtenburg; Dimitrios Kapogiannis; Stephanie A Korenic; Roger J Mullins; Joyce Tran; Frank E Gaston; Shuo Chen; Maja Mustapic; L Elliot Hong; Laura M Rowland
Journal:  Schizophr Res       Date:  2019-02-11       Impact factor: 4.939

Review 7.  Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?

Authors:  Kevin L Farmer; Chengyuan Li; Rick T Dobrowsky
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

8.  miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

Authors:  Woori Kim; Yenarae Lee; Noah D McKenna; Ming Yi; Filip Simunovic; Yulei Wang; Benjamin Kong; Robert J Rooney; Hyemyung Seo; Robert M Stephens; Kai C Sonntag
Journal:  Neurobiol Aging       Date:  2014-01-24       Impact factor: 4.673

9.  Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease.

Authors:  Bhumsoo Kim; Carey Backus; Sangsu Oh; Eva L Feldman
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Curcumin ameliorates insulin signalling pathway in brain of Alzheimer's disease transgenic mice.

Authors:  Hui-Li Feng; Hui-Zi Dang; Hui Fan; Xiao-Pei Chen; Ying-Xue Rao; Ying Ren; Jin-Duo Yang; Jing Shi; Peng-Wen Wang; Jin-Zhou Tian
Journal:  Int J Immunopathol Pharmacol       Date:  2016-07-27       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.